Evidence map›Paper›PMID 33742390›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Cancer Cell Invasion and Metastasis in Zebrafish Models (Danio rerio).

Sarah Martinez Roth, Eric B Berens, Ghada M Sharif, Eric Glasgow, Anton Wellstein

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Role of the Neurotrophin Network in Skin Squamous Cell Cancer and the Novel Use of the Zebrafish System.JID innovations : skin science from molecules to population health · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Zebrafish Models of Paediatric Brain Tumours.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sarah Martinez RothDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Washington, Washington, DC, USA.
Eric B BerensDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Washington, Washington, DC, USA.
Ghada M SharifDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Washington, Washington, DC, USA.
Eric GlasgowDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Washington, Washington, DC, USA.
Anton WellsteinDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Washington, Washington, DC, USA. anton.wellstein@georgetown.edu.
Georgetown University · USGeorgetown University Medical Center · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitorsR01CA231291 · NCI · GEORGETOWN UNIVERSITY · PI ATKINS, MICHAEL BENJAMIN, WELLSTEIN, ANTON · 2018 to 2022
$2.6M
Conditionally reprogrammed cells as a novel tool for biobankingR33CA177466 · NCI · GEORGETOWN UNIVERSITY · PI SCHLEGEL, RICHARD, WELLSTEIN, ANTON · 2013 to 2015
$1.2M
Impact of Cytoskeletal Regulators on Cancer Cell Stromal InvasionK00CA212132 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BERENS, ERIC · 2018 to 2021
$320k
Molecular indicators of treatment responses and adverse events in melanomaF31CA235970 · NCI · GEORGETOWN UNIVERSITY · PI ROTH, SARAH MARTINEZ · 2018 to 2020
$101k
Impact of Cytoskeletal Regulators on Cancer Cell Stromal InvasionF99CA212132 · NCI · GEORGETOWN UNIVERSITY · PI BERENS, ERIC · 2016 to 2017
$64k
NCI NIH HHS F31 CA235970NCI NIH HHS F99 CA212132NCI NIH HHS K00 CA212132NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA231291NCI NIH HHS R33 CA177466
6 · The paper itself

Abstract

Cancer cell vascular invasion and extravasation at metastatic sites are hallmarks of malignant progression of cancer and associated with poor disease outcome. Here we describe an in vivo approach to study the invasive ability of cancer cells into the vasculature and their hematogenous metastatic seeding in zebrafish (Danio rerio). In one approach, extravasation of fluorescently labeled cancer cells is monitored in zebrafish embryos whose vasculature is marked by a contrasting fluorescent reporter. After injection into the precardiac sinus of 2-day-old embryos, cancer cells can extravasate from the vasculature into tissues over the next few days. Extravasated cancer cells are identified and counted in live embryos via fluorescence microscopy. In a second approach, intravasation of cancer cells can be evaluated by changing their injection site to the yolk sac of zebrafish embryos. In addition to monitoring the impact of drivers of malignant progression, candidate inhibitors can be studied in this in vivo model system for their efficacy as well as their toxicity for the host.

Indexed as

Disease Models, AnimalAnimalsNeoplasm InvasivenessTransendothelial and Transepithelial MigrationTumor Cells, CulturedXenograft Model Antitumor AssaysZebrafishCancerEmbryoExtravasationFluorescenceMetastasisVascular InvasionZebrafish

Identifiers

PMID33742390
PMCPMC9107928
OpenAlexW3138790660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.